Maria G. Freve
Known title: VP, Chief Accounting OfficerCIK: 0001807561
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Sensata Technologies shares rise alongside chip peers. Sensata Technologies stock moved higher recently, appearing in market updates alongside semiconductor giants Broadcom and Qualcomm. This suggests the company is benefiting from broader positive sentiment in the technology and industrial sectors. The stock is currently trading near the middle of its 52-week range, with analysts maintaining a mixed but generally positive outlook on its future value.
Transaction History
| SYM | ▼ Sell | Open Market | 2,244 | $90K | 7/24/2026 | View on chart |
| SYM | ▲ Buy | Option Exercise | 1,144 | — | 7/23/2026 | View on chart |
| SYM | ▲ Buy | Option Exercise | 3,457 | — | 7/23/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 2,265 | $131K | 4/28/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 2,335 | $140K | 4/24/2026 | View on chart |
| SYM | ▲ Buy | Option Exercise | 1,144 | — | 4/23/2026 | View on chart |
| SYM | ▲ Buy | Option Exercise | 3,456 | — | 4/23/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 2,896 | $160K | 1/28/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 900 | $50K | 1/28/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 4,210 | $230K | 1/28/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 300 | $17K | 1/28/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 6,667 | $400K | 1/26/2026 | View on chart |
| SYM | ▲ Buy | Option Exercise | 1,144 | — | 1/23/2026 | View on chart |
| SYM | ▲ Buy | Option Exercise | 13,824 | — | 1/23/2026 | View on chart |
| SYM | ▼ Sell | Open Market | 1,666 | $97K | 11/17/2025 | View on chart |
| SYM | ▼ Sell | Open Market | 662 | $47K | 10/28/2025 | View on chart |
| SYM | ▼ Sell | Open Market | 482 | $33K | 10/24/2025 | View on chart |
| SYM | ▲ Buy | Option Exercise | 1,144 | — | 10/23/2025 | View on chart |
| SYM | ▼ Sell | Open Market | 2,000 | $104K | 8/18/2025 | View on chart |
| SYM | ▲ Buy | Option Exercise | 1,144 | — | 7/23/2025 | View on chart |
| SYM | ▼ Sell | Open Market | 478 | $26K | 7/23/2025 | View on chart |
| SYM | ▼ Sell | Open Market | 1,929 | $42K | 4/24/2025 | View on chart |
| SYM | ▲ Buy | Option Exercise | 4,575 | — | 4/23/2025 | View on chart |
| ST | ▼ Sell | Tax Withholding | 1,826 | $91K | 4/1/2023 | View on chart |
| ST | ▲ Buy | Grant | 3,149 | $0 | 4/1/2023 | View on chart |
| ST | ▲ Buy | Grant | 3,265 | $0 | 4/1/2023 | View on chart |
| ST | ▼ Sell | Open Market | 867 | $36K | 12/15/2022 | View on chart |
| ST | ▲ Buy | Grant | 3,116 | $0 | 4/1/2022 | View on chart |
| ST | ▼ Sell | Tax Withholding | 563 | $28K | 4/1/2022 | View on chart |
| ST | ▼ Sell | Open Market | 382 | $23K | 11/23/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
SYM Announces Acquisition of Cellumation, Expanding Sortation Tech
Symbotic disclosed that it has acquired German automation firm Cellumation, adding next‑generation sortation technology to its portfolio. The deal was announced alongside a report that the company carries a $22.5 billion backlog, highlighting strong demand for its robotics solutions. A trading halt was placed earlier in the day as the news was released, after which quotations resumed. Analysts note the high valuation metrics as the stock continues to trade near the lower end of its 52‑week range.
SYM Announces Acquisition of Cellumation, Expanding Sortation Tech. Symbotic disclosed that it has acquired German automation firm Cellumation, adding next‑generation sortation technology to its portfolio. The deal was announced alongside a report that the company carries a $22.5 billion backlog, highlighting strong demand for its robotics solutions. A trading halt was placed earlier in the day as the news was released, after which quotations resumed. Analysts note the high valuation metrics as the stock continues to trade near the lower end of its 52‑week range.